Investigation of Regorafenib Efficacy in Patients with Metastatic Colorectal Carcinoma in Relation to the Delivered Dose Intensity/Body Surface AreaKadir ESERa, Emel SEZERa, Vehbi ERÇOLAKa, Ali İNALb, Alper ATAc,
Hakan BASIRd, Mustafa BERKEŞOĞLUeaDepartment of Medical Oncology, Mersin University Faculty of Medicine, Mersin, Türkiye
bClinic of Medical Oncology, Mersin Training and Research Hospital, Mersin, Türkiye
cClinic of Medical Oncology, Mersin Medical Park Hospital, Mersin, Türkiye
dDepartment of Internal Medicine, Mersin University Faculty of Medicine, Mersin, Türkiye
eDepartment of General Surgery, Mersin University Faculty of Medicine, Mersin, TürkiyeDOI: 10.37047/jos.2021-87466 Sayfalar: 34 - 42 1465 Viewed.
By 2022, Cancer is Now a More Chronic Disease with Chronic Difficulties to Go Along with ItAhmet Taner SÜMBÜLa, Ali Murat SEDEFb, Cengiz KARAÇİNc, Cemil BİLİRd,
Baran AKAGÜNDÜZeaDivison of Medical Oncology, Başkent University Adana Dr. Turgut Noyan Application and Research Center-Yüreğir Hospital,
Adana, Türkiye
bClinic of Medical Oncology, Private Medline Adana Hospital, Adana, Türkiye
cDivision of Medical Oncology, University of Health Sciences Abdurrahman Yurtaslan Ankara Oncology Health Application and
Research Center, Ankara, Türkiye
dDivision of Medical Oncology, İstinye University Hospital VM Medical Park Pendik, İstanbul, Türkiye
eDivison of Medical Oncology, Erzincan Binali Yıldırım University Mengücek Gazi Training and Research Hospital, Erzincan, TürkiyeDOI: 10.37047/jos.2022-90068 Sayfalar: 1 - 6 1397 Viewed.
Vinorelbine Induced Serpentine Supravenous HyperpigmentationAhsen Duygu YETUTa, Semra TAŞb, Ferhat EKİNCİc, Cumali ÇELİKc, Atike Pınar ERDOĞANc, Ahmet DİRİCANdaDepartment of Internal Medicine, Manisa Celal Bayar University Faculty of Medicine, Manisa, Türkiye
bClinic of Internal Medicine, Varto State Hospital, Muş, Türkiye
cDivision of Medical Oncology, Manisa Celal Bayar University Faculty of Medicine, Manisa, Türkiye
dDivision of Medical Oncology, İzmir University of Economics Medical Park Hospital, İzmir, TürkiyeDOI: 10.37047/jos.2022-88125 Sayfalar: 54 - 56 1230 Viewed.
Efficacy of Imatinib on Advanced and Refractory Desmoid Tumors: A Retrospective StudyMuhammed Mustafa ATCIa, Orçun CANc, Şaban SEÇMELERa, Abdullah SAKİNa, Seval AYb, Şener CİHANa, Oğuzhan SELVİa, Çağlayan GEREDELİaaDepartment of Medical Oncology, University of Health Sciences Prof. Dr. Cemil Taşcıoğlu City Hospital, İstanbul, Türkiye
bDepartment of Medical Oncology, İstanbul Medeniyet University Göztepe Education and Research Hospital, İstanbul, Türkiye
cDepartment of Medical Oncology, İstinye University Hospital Liv Hospital Bahçeşehir, İstanbul, TürkiyeDOI: 10.37047/jos.2021-87391 Sayfalar: 63 - 68 1250 Viewed.
The Real-Life Efficacy of the Second Line Treatment Strategy in Advanced Pancreas CancerMutlu HIZALa, Mehmet Ali Nahit ŞENDURb, Burak BİLGİNb, Ebru KARCI GÜNERc,
Muhammed Bülent AKINCIb, Yakup ERGÜNa, Ece ESİNd, Elif Berna KÖKSOYe,
Ahmet SEZERf, Nuriye ÖZDEMİRg, Berna ÖKSÜZOĞLUd, Bülent YALÇINb,
Güngör UTKANe, Yüksel ÜRÜNeaClinic of Medical Oncology, Ankara City Hospital, Ankara, Türkiye
bDivision of Medical Oncology, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Türkiye
cDivision of Medical Oncology, Medipol University Faculty of Medicine, İstanbul, Türkiye
dDivision of Medical Oncology, University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Health Application and Research Center, Ankara, Türkiye
eDivision of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Türkiye
fDivision of Medical Oncology, Başkent University Faculty of Medicine, Adana, Türkiye
gDivision of Medical Oncology, Gazi University Faculty of Medicine, Ankara, TürkiyeDOI: 10.37047/jos.2022-88853 Sayfalar: 69 - 75 1148 Viewed.
The Impact of Hybrid Capture-Based Comprehensive Genomic Profiling on Treatment Strategies in Patients with Solid TumorsUmut DİŞELa, Fatih KÖSEb, Ahmet BİLİCİc, Mustafa ÖZGÜROĞLUd, Sezer SAĞLAMe, Mesut ŞEKERf, Sercan AKSOYg, İbrahim TEKh, Nil Molinas MANDELi, Gökhan DEMİRi, Çağatay ARSLANk, Mutlu DEMİRAYl, Mehmet Akif ÖZTÜRKm, Taflan SALEPÇİn, Yeşim ERALPo, Fatih SELÇUKBİRİCİKp, Gökçe TEMİZAŞr, Ebru Gül FİDANraClinic of Medical Oncology, Acıbadem Adana Hospital, Adana, Türkiye
bDivision of Medical Oncology, Başkent University Adana Dr. Turgut Noyan Application and Research Center, Adana, Türkiye
cDivision of Medical Oncology, İstanbul Medipol University Faculty of Medicine, İstanbul, Türkiye
dDivision of Medical Oncology, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
eDivision of Medical Oncology, Demiroğlu Bilim University İstanbul Florence Nightingale Hospital, İstanbul, Türkiye
fDivision of Medical Oncology, Bezmiâlem Vakıf University Faculty of Medicine, İstanbul, Türkiye
gDivision of Medical Oncology, Hacettepe University Institute of Cancer, Ankara, Türkiye
hClinic of Medical Oncology, Medicana International Ankara Hospital, Ankara, Türkiye
iClinic of Medical Oncology, American Hospital, İstanbul, Türkiye
kClinic of Oncology, Acıbadem Maslak Hospital, İstanbul, Türkiye
kClinic of Medical Oncology, Medical Park İzmir Hospital, İzmir, Türkiye
lClinic of Medical Oncology, Medicana International İstanbul Hospital, İstanbul, Türkiye
mClinic of Oncology, VM Medical Park Pendik Hospital, İstanbul, Türkiye
nClinic of Medical Oncology, İstanbul Oncology Hospital, İstanbul, Türkiye
oClinic of Medical Oncology, Acıbadem Maslak Hospital, İstanbul, Türkiye
Division of Medical Oncology, Koç University Faculty of Medicine, İstanbul, Türkiye
rRoche Pharma, İstanbul, TürkiyeDOI: 10.37047/jos.2022-89310 Sayfalar: 87 - 93 1365 Viewed.
Predictive and Prognostic Value of ABO Blood Group in Patients Using Immune Checkpoint Inhibitor for Advanced Renal Cell CarcinomaYakup ERGÜNa, Gökhan UÇARb, Selin AKTÜRK ESENb, Murat BARDAKÇIb, Ziya KALKANc, Zuhat URAKÇIc, Erdoğan ŞEYRANd, Mutlu DOĞANd, Gökşen İnanç İMAMOĞLUe, Ozan YAZICIf, Seda KAHRAMANb, Yusuf AÇIKGÖZb, Doğan UNCUbaClinic of Medical Oncology, Batman Training and Research Hospital, Batman, Türkiye
bDepartment of Medical Oncology, University of Health Sciences Ankara City Hospital, Ankara, Türkiye
cDepartment of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakır, Türkiye
dClinic of Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Türkiye
eClinic of Medical Oncology, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Türkiye
fDepartment of Medical Oncology, Gazi University Faculty of Medicine, Ankara, TürkiyeDOI: 10.37047/jos.2022-90679 Sayfalar: 100 - 106 1151 Viewed.
Survival Analysis of Patients with Triple-Negative Breast Cancer: A Single-Center ExperienceAkif DOĞANa, Murat AYHANbaDepartment of Medical Oncology, Health Science University Kartal Dr. Lütfi Kırdar City Hospital, İstanbul, Türkiye
bDepartment of Medical Oncology, Adıyaman Training and Research Hospital, Adıyaman, TürkiyeDOI: 10.37047/jos.2022-89749 Sayfalar: 94 - 99 1000 Viewed.
Effects of Nutritional Support on the Quality of Life of Cancer PatientsGülnur KARADAŞa, Atike Pınar ERDOĞANb, Ferhat EKİNCİb, Melek ÇİVİc, Gamze GÖKSELbaClinic of Internal Medicine, Manisa Merkezefendi State Hospital, Manisa, Türkiye
bDivision of Medical Oncology, Manisa Celal Bayar University Faculty of Medicine, Manisa, Türkiye
cDepartment of Anesthesiology and Reanimation, Manisa Celal Bayar University Faculty of Medicine, Manisa, TürkiyeDOI: 10.37047/jos.2022-89699 Sayfalar: 165 - 172 1369 Viewed.